Generic intelligence database includes drug name, generic name, brand name, company name, disease area, indication, stage of development, drug geography, marketing status, dosage form, route of administration, strength, approval date, approval number, nature of molecule, approval type, DMF filer, DMF date, status, reference drug, parent company, patent expiry and patent litigations.
United States, EU, Japan, New Zealand, Switzerland and Israel countries generic Drugs are covered with exhaustive information.
Generic launches strategies can be validated within your country of interest for the existing Companies and Drugs.
Better informed decisions add to your R&D strategies and management objectives.
User friendly modules, easy exports and global players by your desired data filters always keep for all strategic meetings and presentations.